April 20, 2020
Sheila Rauch, PhD, ABPP
and
The current COVID-19 pandemic is unprecedented in reach around the world and the extended nature of this invisible threat. All are impacted whether it is direct impact on health or employment or indirect impact through availability of services and loved ones.
April 7, 2020
Mary Karapetian Alvord, PhD
and
The COVID19 pandemic has required mental health practitioners to shift from providing largely in-person therapeutic intervention, to operating a complete Telemental Health psychotherapy practice. This change not only requires knowledge of ethical and legal requirements (i.e.
June 3, 2020
Lauren P. Wadsworth, PhD
and
This webinar discusses population specific components of anxiety and depression development (e.g. role of stigma, coming out), and provides tangible ways to provide more accurate and affirming research, and/or more culturally informed therapy.
September 10, 2020
Rachel Singer, PhD
and
May 21, 2020
Angela Neal-Barnett, PhD
and
Christin Farmer Kane, BA
and
February 27, 2020
April 23, 2020
January 16, 2020
Paul Holtzheimer, MD - ADAA Board Member
and
Deep brain stimulation (DBS) is emerging as a potential intervention for patients with highly treatment-resistant depression (TRD). Early, open-label studies supported the safety and potential efficacy of DBS for TRD but later randomized, controlled trials have yielded mixed results.
October 30, 2019
Joy Burkhard, MBA
and
Catherine Monk, PhD
and
Margaret Altemus, MD
and
Rahil Briggs, PsyD
and
May 23, 2019
